Reaction

Congenital Hydronephrosis reporting signals

Last recalculated 2026-09-14T18:28:35.993900+00:00 · 709 reports · 23 co-occurring drugs

As of the last recalculation, Congenital Hydronephrosis appears in 709 FAERS reports alongside 23 co-occurring drug terms. The strongest observed disproportionality signal is DARUNAVIR (PRR 77.9).

Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
DrugCo-reportsPRRROR
Darunavir3877.978.1
Ritonavir5559.859.9
Misoprostol1752.552.6
Zidovudine2352.252.2
Atazanavir1837.737.7
Tiotropium Bromide Inhalation Spray1232.032.0
Clobazam2531.131.2
Raltegravir1629.129.1
Lopinavir And Ritonavir1124.224.2
Ritonavir 100 Mg1224.024.0
Lamivudine2221.521.6
Progesterone1621.021.0
Lacosamide2520.420.4
Oxcarbazepine2018.618.6
Lamivudine Oral1416.616.6
Levetiracetam In Sodium Chloride3815.215.2
Levetiracetam Oral3815.215.2
Levetiracetam Injection3815.215.2
Tenofovir Disoproxil Fumarate Tablets413.713.7
Brinzolamide413.613.6
Dolutegravir Sodium413.113.1
Emtricitabine And Tenofovir Disoproxil Fumarate1711.211.2
Vigabatrin36.16.1

Related reactions

Data source: openFDA FAERS. See the OpenPV methodology and limitations.